# EDGAR Filing Document

**Accession Number:** 0001863685
**File Stem:** 0001213900-23-003490
**Filing Date:** 2023-1
**Character Count:** 14186
**Document Hash:** c11a9170c1cedc32e21e924cdd39e8c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-003490.hdr.sgml**: 20230118

**ACCESSION NUMBER**: 0001213900-23-003490

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230118

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230118

**DATE AS OF CHANGE**: 20230118

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Thrive Acquisition Corp
- **CENTRAL INDEX KEY:** 0001863685
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40939
- **FILM NUMBER:** 23535101

**BUSINESS ADDRESS:**
- **STREET 1:** RIVERSIDE CENTER
- **STREET 2:** 275 GROVE STREET, SUITE 2-400
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02466
- **BUSINESS PHONE:** 6176635988

**MAIL ADDRESS:**
- **STREET 1:** RIVERSIDE CENTER
- **STREET 2:** 275 GROVE STREET, SUITE 2-400
- **CITY:** NEWTON
- **STATE:** MA
- **ZIP:** 02466

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **January 18, 2023**

**THRIVE ACQUISITION CORPORATION**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-40939** | **98-1601854** |
| (State or other jurisdiction<br> of incorporation) | (Commission File Number) | (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **Riverside Center**<br> **275 Grove Street, Suite 2-400<br> Newton, MA** | **02466** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(617) 663-5988**

**Not Applicable** (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one Redeemable Warrant | THAC.U | The Nasdaq Stock Market LLC |
| Class A ordinary share, par value $0.0001 per share | THAC | The Nasdaq Stock Market LLC |
| Redeemable Warrants, each exercisable for one Class A ordinary share for $11.50 per share | THAC.W | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01. Other Events.**

The Board of Directors (the "<u>Board</u>") of Thrive Acquisition Corporation (the "<u>Company</u>") has determined that the Company will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the "<u>Articles</u>"). Accordingly, the Board has determined that it is in the best interest of the Company and its shareholders for the Company to dissolve and liquidate in accordance with the provisions of the Articles and the Company will redeem all of its outstanding Class A ordinary shares, par value $0.0001 (the "<u>Public Shares</u>"), effective as of the close of business on January 25, 2023.

As such, in accordance with the Company's Articles, the Company will:

● cease all operations as of January 25, 2023, except those required to wind up the Company's business;

● as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Company's trust account (the " <u>Trust Account</u> "), including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish public shareholders' rights as shareholders of the Company (including the right to receive further liquidating distributions, if any); and

● as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining shareholders and the Board of the Company, liquidate and dissolve, subject to the Company's obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The per-share redemption price for the Public Shares will be approximately $10.36 (the "<u>Redemption Amount</u>"). The balance of the Trust Account as of January 17, 2023 was approximately $178,830,714.34, which includes approximately $2,880,714.34 in interest and dividend income (excess of cash over $175,950,000.00, the funds deposited into the Trust Account). In accordance with the terms of the related trust agreement, the Company expects to retain $100,000 of the interest and dividend income from the Trust Account to pay dissolution expenses.

As of the close of business on January 25, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the Redemption Amount.

The Redemption Amount will be payable to the holders of the Public Shares upon presentation of their respective stock or unit certificates or other delivery of their shares or units to the Company's transfer agent, Continental Stock Transfer & Trust Company. Beneficial owners of Public Shares held in "street name," however, will not need to take any action in order to receive the Redemption Amount.

The Company's sponsor has waived its redemption rights with respect to any of the Company's securities that are held by the sponsor. After January 25, 2023, the Company shall cease all operations except for those required to wind up the Company's business.

The Company expects that Nasdaq will file a Form 25 with the U.S. Securities and Exchange Commission (the "<u>Commission</u>") to delist its securities. The Company thereafter expects to file a Form 15 with the Commission to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.

**Forward-Looking Statements**

This Current Report on Form 8-K includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Current Report on Form 8-K, the words "could," "should," "will," "may," "believe," "anticipate," "intend," "estimate," "expect," "project," the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on current information and expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing the Company's views as of any subsequent date, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the "Risk Factors" in the Company's registration statement on Form S-1 (Registration No. 333-259418), as amended, initially filed with the Commission on September 29, 2021, relating to its initial public offering, annual, quarterly reports and subsequent reports filed with the Commission, as amended from time to time. Copies of such filings are available on the Commission's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this Current Report on Form 8-K, except as required by law.

**Item 9.01 Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibits** |
| 99.1 | [Press Release dated January 18, 2023](ea171804ex99-1_thriveacq.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **THRIVE ACQUISITION CORPORATION** | **THRIVE ACQUISITION CORPORATION** |
| By: | /s/ Charles Jobson |
| Name: | Charles Jobson |
| Title: | Chief Executive Officer |

---

Dated: January 18, 2023

## Exhibit 99.1

**Exhibit 99.1**

January 18, 2023

**Thrive Acquisition Corporation Announces it will Redeem its Public Shares and will not Consummate an Initial Business Combination** 

Newton, Massachusetts, January 18, 2023 (BUSINESS WIRE) – Thrive Acquisition Corporation (NASDAQ: THAC) (the "<u>Company</u>") announced today that, because the Company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the "<u>Amended Articles</u>"), the Company intends to liquidate and dissolve in accordance with the provisions of the Amended Articles, effective as of the close of business on January 25, 2023, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "<u>Public Shares</u>"), at an anticipated per-share redemption price of approximately $10.36.

As of the close of business on January 25, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.

In order to provide for the disbursement of funds from the trust account, the Company will instruct the trustee of the trust account to take all necessary actions to liquidate the securities held in the trust account. The proceeds of the trust account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares. Record holders will receive their *pro rata* portion of the proceeds of the trust account by delivering their Public Shares to Continental Stock Transfer & Trust Company, the Company's transfer agent. Beneficial owners of Public Shares held in "street name," however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed within ten business days after January 25, 2023.

The Company's sponsor, officers and directors have agreed to waive their redemption rights with respect to their outstanding Class B ordinary shares issued prior to the Company's initial public offering. There will be no redemption rights or liquidating distributions with respect to the Company's warrants, which will expire worthless.

The Company expects that The Nasdaq Stock Market LLC will file a Form 25 with the United States Securities and Exchange Commission (the "<u>Commission</u>") to delist the Company's securities. The Company thereafter expects to file a Form 15 with the Commission to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company anticipates that the Public Shares will cease trading as of the close of business on January 25, 2023.

Cautionary Note Concerning Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Commission filings.

Thrive Acquisition Corporation

Contact: Charles Jobson

info@thriveacquisitions.com